NDC 71336-1003 – Amvuttra

Vutrisiran Sodium 25 mg/.5mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC71336-1003

Product details

Brand name
Amvuttra
Generic name
Vutrisiran
Labeler
Alnylam Pharmaceuticals, Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
NDA · NDA215515
Marketed since
June 13, 2022
Listing expires
December 31, 2026
Pharmacologic class
Small Interfering RNA; Transthyretin-directed RNA Interaction

Active ingredients

Uses, dosage, side effects and warnings for Amvuttra →

Package NDC codes (1)

Package NDCDescriptionSince
71336-1003-11 SYRINGE, GLASS in 1 CARTON (71336-1003-1) / .5 mL in 1 SYRINGE, GLASSJun 13, 2022